The factor V leiden mutation: A possible contributor to the hepatic artery thrombosis encountered after liver transplantation in a child

Journal of Pediatric Surgery

Volumn 35, Issue 4, 2000, Pages 607-609

  Tanyel, F Cahit ^a,b   Öcal, Turgay ^a   Balkanc, Ferhun ^a   Çekirge, Saruhan ^a   Şenocak, M Emin ^a   Büyükpamukçu, Nebil ^a   Gürgey, Aytemiz ^a  

^a Departments of Pediatric Surgery   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Factor V Leiden; Hepatic artery; Liver transplantation; Thrombosis; Urokinase

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; UROKINASE;

ARTERY THROMBOSIS; ARTICLE; CASE REPORT; CHILD; FEMALE; GENE MUTATION; GRAFT SURVIVAL; HEPATIC ARTERY; HUMAN; LIVER BLOOD FLOW; LIVER TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0034079596     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2000.0350607     Document Type: Article

References (25)

1. Van der Werf WJ, D'Alessandro AM, Knechtle SJ, et al. Infant pediatric liver transplantation results equal those for older pediatric patients. J Pediatr Surg. 33:1998;20-23
2. Rela M, Muiesan P, Bhatnagar V, et al. Hepatic artery thrombosis after liver transplantation in children under 5 years of age. Transplantation. 61:1996;1355-1357
3. Mazzaferro V, Esquivel CO, Makowka L, et al. Hepatic artery thrombosis after pediatric liver transplantation-A medical or surgical event? Transplantation. 47:1989;971-977
4. Lallier M, St-Vil D, Dubois J, et al. Vascular complications after pediatric liver transplantation. J Pediatr Surg. 30:1995;1122-1126
5. Pascual M, Thadhani R, Laposata M, et al. Anticardiolipin antibodies and hepatic artery thrombosis after liver transplantation. Transplantation. 64:1997;1361-1364
6. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67
7. Poort RS, Rosendaal FR, Reitsma PH, et al. A common genetic variation in 3'-untranslated region of prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88:1996;3698-3703
8. Bauer KA. Rare hereditary coagulation factor abnormalities. Nathan DG, Orkin SH. Nathan and Oski's Hematology of Infancy and Childhood. 1998;1660-1672 WB Saunders, Philadelphia, PA
9. Bontempo FA, Hasset AC, Faruki H, et al. The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation. J Vasc Surg. 25:1997;271-275
10. Eskandari MK, Bontempo FA, Hasset AC, et al. Arterial thromboembolic events in patients with the factor V Leiden mutation. Am J Surg. 176:1998;122-125
11. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective. Ann Intern Med. 127:1997;895-903
12. Newman RS, Spear GS, Kirschbaum N. Postmortem DNA diagnosis of factor V Leiden in a neonate with systemic thrombosis and probable antithrombin deficiency. Obstet Gynecol. 92:1998;702-705
13. Hagstrom JN, Walter J, Bluebond-Langer R, et al. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr. 133:1998;777-781
14. Le Moine A, Chauveau D, Grünfeld JP. Acute renal artery thrombosis associated with factor V Leiden mutation. Nephrol Dial Transplant. 11:1996;2067-2069
15. Heresbach D, Pagenault M, Gueret P, et al. Leiden factor V mutation in patients with small bowel infarctions. Gastroenterology. 113:1997;322-325
16. Kiechl S, Muigg A, Santer P, et al. Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation. 99:1999;614-619
17. Orlandi G, Pellegrinetti A, Fioretti C, et al. Factor V Leiden mutation in a case with ischemic stroke: Which relationship? A case report. Angiology. 49:1998;79-82
18. Glueck CJ, Fontaine RN, Gupta A, et al. Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activator inhibitor activity, and resistance to activated protein C. Metabolism. 46:1997;1470-1472
19. Fischereder M, Göhring P, Schneeberger H, et al. Early loss of renal transplants in patients with thrombophilia. Transplantation. 65:1998;936-939
20. Irish AB, Green FR, Gray DW, et al. The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients. Transplantation. 64:1997;604-607
21. Hirschfield G, Collier JD, Brown K, et al. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transplant Surg. 4:1998;58-61
22. Biesma DH, de Man RA, Nieuwenhuis HK, et al. Recurrent venous thrombosis despite correction of activated protein C resistance following orthotopic liver transplantation. Thromb Haemost. 80:1998;525-526
23. Blanshard C, Pasi J, Rolles K, et al. Acute Budd-Chiari syndrome treated by liver transplantation in a woman homozygous for factor V Leiden. Eur J Gastroenterol Hepatol. 8:1996;925-927
24. Gürgey A, Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr. 39:1997;313-315
25. Moor E, Silveira A, vant Hooft F, et al. Coagulation factor V (Arg506 < Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting. Thromb Haemost. 80:1998;220-224